| Complementary and Alternative Medicine |
1 |
1 |
| Microbiome |
0 |
0.68 |
| Probiotics |
0 |
0.99 |
| Chemotherapy |
0 |
0.98 |
| Adjuvant Chemotherapy |
0 |
0.42 |
| Breast Cancer |
0 |
0.97 |
| Cancer |
0 |
0.26 |
| Cognitive Impairment |
0 |
0.25 |
| Memory |
0 |
0.23 |
| Breast |
0 |
0.21 |
| Brain |
0 |
0.19 |
| Impairment |
0 |
0.19 |
| Mild Cognitive Impairment |
0 |
0.19 |
| Toxicology |
0 |
0.18 |
| Diversity |
0 |
0.05 |
| Social Determinants of Health |
0 |
0.05 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.04 |
| Patient Safety |
0 |
0.04 |
| Cardiovascular Risk Management |
0 |
0.03 |
| Constipation |
0 |
0.03 |
| Lipids Management |
0 |
0.03 |
| Adverse Effects |
0 |
0.02 |
| Blood |
0 |
0.02 |
| Body Mass Index |
0 |
0.02 |
| Canada |
0 |
0.02 |
| Concerns of Elderly |
0 |
0.02 |
| Emesis |
0 |
0.02 |
| Europe |
0 |
0.02 |
| Geriatrics |
0 |
0.02 |
| Hand |
0 |
0.02 |
| Hospital |
0 |
0.02 |
| Interference |
0 |
0.02 |
| LDL Cholesterol |
0 |
0.02 |
| Medical Innovations |
0 |
0.02 |
| Mucositis |
0 |
0.02 |
| Neuroinflammation |
0 |
0.02 |
| Neuroprotection |
0 |
0.02 |
| Neurotoxicity |
0 |
0.02 |
| Pedal |
0 |
0.02 |
| Plasma |
0 |
0.02 |
| Surgery |
0 |
0.02 |